Related Experiment Video
Updated: Mar 28, 2026

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
Advances on the large-scale bacterial production and stable phosphorylation of Hsc70
Nicholas Kley1, Michael Hecht-Bucher1, Aymelt Itzen2
1Institute of Biochemistry and Signal Transduction, University Medical Center Hamburg-Eppendorf, Hamburg, 20246, Germany.
Abstract:
Phosphorylation of the constitutively expressed Hsp70 chaperone Hsc70 at threonine 495 modulates its cellular functions. While the functional consequences of Hsc70 phosphorylation are increasingly understood, analyzing its structural effects is hampered by the need for large amounts of stably phosphorylated protein. Here, we establish a preparative protocol for producing phosphorylated Hsc70 (pHsc70) and its ATPase-deficient T204A (Hsc70T204A) mutant via the Legionella effector kinase LegK4, yielding 10 mg protein per liter of cell culture. Hsc70 is expressed in Escherichia coli, purified by immobilized metal affinity chromatography, and enzymatically phosphorylated at T495 under conditions minimizing reverse reactions, achieving phosphorylation levels of ∼70% for Hsc70 and ∼86% for Hsc70T204A. Rigorous depletion of LegK4 following the phosphorylation reaction is critical, as residual kinase promotes dephosphorylation and compromises phosphorylation stability. Phosphorylation at T495 reduces the oligomerization propensity of Hsc70, as evidenced by SAXS measurements showing decreased radius of gyration, maximum particle dimension, and oligomer abundance in phosphorylated Hsc70T204A compared to the unphosphorylated protein across ATP-, ADP-, and apo-states. Thus, this protocol provides robust access to stably phosphorylated Hsc70 suitable for biochemical and structural investigations, and may offer a general strategy for preparative enzymatic phosphorylation using recombinant kinases.
Related Concept Videos
Other Stress Responses in Bacteria
Bacterial Protein Maturation
Upstream Processing
Bioreactor Controls-III
Production of Pharmaceuticals
Gene Regulation During Sporulation

